A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato

Exclusion Criteria

• •1. Subject is pregnant, nursing, planning a pregnancy, or not using adequate birth control;
• •2. Subject has a history of digestive problems;
• •3. Subject is on blood thinners;
• •4. Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within 4 week prior to initiation of the study;
• •5. Chronic or relapsing inflammatory and/or allergic skin conditions such as atopic dermatitis, rosacea, psoriasis and alike including telangiectasias ("spider veins");
• •6. Current diagnosis of adult acne or currently on treatment for adult acne;
• •7. Participants who have received facial irradiation within last year or are planning on undergoing facial irradiation during the study;
• •8. Participants who currently take supplements containing carotenoids, lutein, melatonin or tryptophan;
• •9. Participants who use tanning salons or tanning products in the last 3 months;
• •10. Participants who plan to undergo invasive facial procedures (injections, chemical peeling, etc.) during the study or have undergone these procedures within 2 months prior to enrollment;
• •11. Participants with auto-immune skin diseases (e.g. scleroderma, psoriasis, lupus, epidermolysis bullosa, bullous pemphigoid, temporal arteritis);
• •12. Participants who have been prescribed retinoids treatment (\<2 months prior to enrollment);
• •13. Current smokers;
• •14. Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would, in the opinion of the Principal Investigator, preclude application of the test material and/or could influence the outcome of the study;
• •15. Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study;
• •16. Subject is not willing to participate in all study evaluations;
• •17. Subject has known allergies to skin treatment products or cosmetics, toiletries, nutraceuticals, nutricosmetic, and/or topical drugs;
• •18. Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind;
• •19. Subject has diabetes.